AdvancesintheTreatmentofAcuteMyeloidLeukemia:NewDrugsandNewChallenges
Date:类型:Review
Author:NicholasJShortetal.
杂志:CancerDiscov
摘要
Thetherapeuticarmamentariumofacutemyeloidleukemia(AML)hasrapidlyexpandedinthepastfewyears,drivenlargelybytranslationalresearchintoitsgenomiclandscapeandanimprovedunderstandingofmechanismsofresistancetoconventionaltherapies.However,primaryandsecondarydrugresistanceremainsasubstantialproblemformostpatients.ResearchintothemechanismsofresistancetothesenewagentsisinformingthedevelopmentofthenextclassofAMLdrugsandthedesignof